- Hem
- Om universitetet
- Hitta person
- Magnus Johnsson
Magnus Johnsson
Doktorand
Sektionen för klinisk neurovetenskapOm Magnus Johnsson
Ingår i forskargruppen för "Neuroinflammation och neurodegeneration" med Lenka Nováková Nyrén och Markus Axelsson som huvudhandledare.
-
A novel multiplexed biomarker panel reveals key molecular pathways in progressive multiple
sclerosis
Christina Heiss, Lenka Nováková Nyrén, Markus Axelsson, Kübra Tan, Ilaria Pola, Wiebke Traichel, Ida Pesämaa, Magnus Johnsson, Sofia Sandgren, Clas Malmeström, Andrea Lessa Benedet, Henrik Zetterberg, Jan Lycke, Stefanie Fruhwürth, Igal Rosenstein
BRAIN COMMUNICATIONS - 2026 -
Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple
Sclerosis
Igal Rosenstein, Markus Axelsson, Magnus Johnsson, Clas Malmeström, Hlin Kvartsberg, Henrik Zetterberg, Jan Lycke, Lenka Nováková Nyrén
European Journal of Neurology - 2026 -
Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple
sclerosis
Magnus Johnsson, Jan Lycke, Lenka Nováková Nyrén, Igal Rosenstein, Brynhildur Hafsteinsdottir, Clas Malmeström, Markus Axelsson
Multiple Sclerosis and Related Disorders - 2026 -
Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at
12 months.
Nina Gleisner, Francisco Meda, Magnus Johnsson, Igal Rosenstein, Ellen Alpsten, Lenka Nováková Nyrén, Jan Lycke, Henrik Zetterberg, Hlin Kvartsberg, Brynhildur Hafsteinsdottir, Markus Axelsson
Journal of neurology - 2026 -
The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life
use.
Magnus Johnsson, Kajsa Eriksson, Igal Rosenstein, Lenka Nováková Nyrén, Clas Malmeström, Jan Lycke, Sofia Sandgren, Henrik Zetterberg, Kaj Blennow, Kalle Johansson, Markus Axelsson
Multiple Sclerosis and Related Disorders - 2025 -
Cerebrospinal fluid alpha-internexin is increased in patients with multiple sclerosis and correlates strongly with neurofilament light
protein.
Magnus Johnsson, Meda Fj, Jan Lycke, Lenka Nováková Nyrén, Igal Rosenstein, Johansson K, Clas Malmeström, Henrik Zetterberg, Hlin Kvartsberg, Markus Axelsson
Multiple Sclerosis and Related Disorders - 2025 -
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center
study
Magnus Johnsson, Y. T. Stenberg, H. H. Farman, Kaj Blennow, Henrik Zetterberg, Clas Malmeström, Sofia Sandgren, Igal Rosenstein, Jan Lycke, Markus Axelsson, Lenka Novakova
MULTIPLE SCLEROSIS JOURNAL - 2024 -
Allvarliga och mångfasetterade följder av användning av
lustgas.
Staffan Svensson, Magnus Johnsson
Läkartidningen - 2023 -
Rhombencephalitis in a patient with VEXAS
syndrome
Magnus Johnsson
Neuroimmunology reports - 2023 -
Clinical stage and plasma neurofilament concentration in adults with Friedreich
ataxia
Magnus Johnsson, Henrik Zetterberg, Kaj Blennow, Christopher Lindberg
Heliyon - 2023 -
No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of
natalizumab
Magnus Johnsson, Helen H. Farman, Kaj Blennow, Henrik Zetterberg, Clas Malmeström, Markus Axelsson, Jan Lycke
Multiple Sclerosis Journal - 2022 -
SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated
disorder
Magnus Johnsson, Fredrik Asztely, S. Hejnebo, Markus Axelsson, Clas Malmeström, T. Olausson, Jan Lycke
Annals of Clinical and Translational Neurology - 2022 -
[Cervical myelopathy due to nitrous oxide
inhalation].
Staffan Svensson, Allan Karbassi, Magnus Johnsson
Lakartidningen - 2022